https://news.medxy.ai/zh/ugmi-hba1c-replacement/Medxy AIzh2026-04-24T19:56:07-07:00uGMI：糖尿病管理中更准确的HbA1c替代指标 https://news.medxy.ai/ja/ugmi-hba1c-diabetes-management/Medxy AIja2026-04-24T19:55:24-07:00uGMI: HbA1cの糖尿病管理におけるより正確な代替指標 https://news.medxy.ai/vi/ugmi-vs-hba1c-diabetes-management/Medxy AIvi2026-04-24T19:54:18-07:00uGMI: Một lựa chọn chính xác hơn so với HbA1c cho việc quản lý đái tháo đường https://news.medxy.ai/ugmi-alternative-hba1c/Medxy AIen2026-04-24T19:52:11-07:00uGMI: A More Accurate Alternative to HbA1c for Diabetes Management https://news.medxy.ai/zh/personalized-thyroid-cancer-treatment/Medxy AIzh2026-04-24T19:38:07-07:00推进甲状腺乳头状癌个性化治疗：预测隐匿性淋巴结转移的机器学习模型 https://news.medxy.ai/ja/thyroid-cancer-treatment-advancements/Medxy AIja2026-04-24T19:37:11-07:00甲状腺乳头状癌の個別化治療の進展：隠匿性リンパ節転移を予測する機械学習モデル https://news.medxy.ai/vi/thyroid-cancer-treatment-prediction/Medxy AIvi2026-04-24T19:35:44-07:00Tiến bộ trong điều trị cá nhân hóa ung thư tuyến giáp dạng nhú: Mô hình học máy để dự đoán di căn hạch bạch huyết ẩn https://news.medxy.ai/personalized-papillary-thyroid-cancer/Medxy AIen2026-04-24T19:33:14-07:00Advancing Personalized Treatment in Papillary Thyroid Cancer: A Machine-Learning Model for Predicting Occult Lymph Node Metastasis https://news.medxy.ai/zh/long-term-air-pollution-metabolic-syndrome/Medxy AIzh2026-04-24T18:19:00-07:00长期空气污染与代谢综合征老年人不良身体成分变化相关 https://news.medxy.ai/ja/long-term-air-pollution-metabolic-syndrome-elderly/Medxy AIja2026-04-24T18:17:55-07:00長期大気汚染が代謝症候群を有する高齢者の体組成変化と関連 https://news.medxy.ai/vi/long-term-air-pollution-effects-elderly/Medxy AIvi2026-04-24T18:16:07-07:00Ô nhiễm không khí dài hạn liên quan đến sự thay đổi cơ thể bất lợi ở người cao tuổi mắc hội chứng chuyển hóa https://news.medxy.ai/air-pollution-body-composition/Medxy AIen2026-04-24T18:12:41-07:00Long-term Air Pollution Linked to Adverse Body Composition Changes in Older Adults with Metabolic Syndrome https://news.medxy.ai/zh/sacubitril-valsartan-blood-pressure/Medxy AIzh2026-04-24T16:57:20-07:00沙库必曲/缬沙坦对血压影响中的缓激肽作用被揭示 https://news.medxy.ai/ja/bradykinin-role-in-blood-pressure/Medxy AIja2026-04-24T16:56:32-07:00サクビトリル/バルサルタンの血圧効果におけるブラジキニンの控えめな役割が明らかに https://news.medxy.ai/vi/bradykinin-sacubitril-valsartan/Medxy AIvi2026-04-24T16:55:33-07:00Vai trò khiêm tốn của Bradykinin trong tác động huyết áp của Sacubitril/Valsartan được tiết lộ https://news.medxy.ai/bradykinin-role-sacubitril-valsartan/Medxy AIen2026-04-24T16:53:19-07:00Bradykinin’s Modest Role in Sacubitril/Valsartan’s Blood Pressure Effects Revealed https://news.medxy.ai/zh/troponin-testing-technology/Medxy AIzh2026-04-24T15:28:24-07:00第六代肌钙蛋白检测技术将早期心肌梗死排除能力提高一倍 https://news.medxy.ai/ja/groundbreaking-troponin-test/Medxy AIja2026-04-24T15:27:44-07:00画期的な第6世代トロポニン検査、初期の心筋梗塞除外能力を倍増 https://news.medxy.ai/vi/troponin-testing-advance/Medxy AIvi2026-04-24T15:26:46-07:00Đột phá với phương pháp xét nghiệm Troponin thế hệ thứ sáu tăng gấp đôi khả năng loại trừ MI sớm https://news.medxy.ai/sixth-gen-troponin-assay/Medxy AIen2026-04-24T15:24:09-07:00Revolutionary Sixth-Generation Troponin Assay Doubles Early MI Rule-Out Capacity https://news.medxy.ai/zh/p2y14r-inhibition-thrombus-strategy/Medxy AIzh2026-04-24T15:09:40-07:00阻断P2Y14R成为通过中性粒细胞-斑块相互作用对抗静脉血栓栓塞的新策略 https://news.medxy.ai/ja/p2y14r-inhibition-thrombosis-strategy/Medxy AIja2026-04-24T15:08:54-07:00P2Y14Rの阻害が好中球-プラーク相互作用を介した静脈血栓塞栓症の新たな治療戦略として浮上 https://news.medxy.ai/vi/p2y14r-inhibition-thromboembolism/Medxy AIvi2026-04-24T15:06:47-07:00Chặn P2Y14R Nổi Lên Là Chiến Lược Mới Để Chống Thromboembolism Tĩnh Mạch Qua Tương Tác Bạch Cầu-Trái Đất https://news.medxy.ai/blocking-p2y14r-thromboembolism/Medxy AIen2026-04-24T15:03:47-07:00Blocking P2Y14R Emerges to Combat Venous Thromboembolism via Neutrophil-Plaque Interaction https://news.medxy.ai/zh/zuo-shu-cardiac-pacing/Medxy AIzh2026-04-24T13:49:27-07:00左束支起搏在高风险心脏患者中优于传统起搏 https://news.medxy.ai/vi/effective-branch-beat/Medxy AIvi2026-04-24T13:47:09-07:00Đánh nhịp nhánh bó trái hiệu quả hơn đánh nhịp truyền thống ở bệnh nhân tim mạch có nguy cơ cao https://news.medxy.ai/left-bundle-branch-pacing/Medxy AIen2026-04-24T13:43:45-07:00Left Bundle Branch Pacing Outperforms Traditional Pacing in High-Risk Cardiac Patients https://news.medxy.ai/zh/hypertrophic-cardiomyopathy-risk-factors/Medxy AIzh2026-04-24T13:40:03-07:00儿童肥厚型心肌病：重度左室肥厚的高危特征 https://news.medxy.ai/ja/hypertrophic-cardiomyopathy/Medxy AIja2026-04-24T13:39:08-07:00小児肥厚型心筋症：巨大左室肥厚の高リスクプロファイル https://news.medxy.ai/vi/hypertrophic-cardiomyopathy-children-2/Medxy AIvi2026-04-24T13:34:33-07:00Bệnh tim cơ phì đại ở trẻ em: Đặc điểm nguy cơ cao của sự dày tâm thất trái nặng https://news.medxy.ai/vi/hypertrophic-cardiomyopathy-children/Medxy AIvi2026-04-24T13:34:33-07:00Bệnh tim cơ phì đại ở trẻ em: Đặc điểm nguy cơ cao của sự dày tâm thất trái nặng https://news.medxy.ai/pediatric-hypertrophic-cardiomyopathy/Medxy AIen2026-04-24T13:28:58-07:00Pediatric Hypertrophic Cardiomyopathy: The High-Risk Profile of Massive Left Ventricular Hypertrophy https://news.medxy.ai/zh/model-outperforms-aquila/Medxy AIzh2026-04-24T13:19:39-07:002/20/20 模型在识别高危冒烟型多发性骨髓瘤方面优于 AQUILA 标准 https://news.medxy.ai/ja/2-20-20-model-aquila/Medxy AIja2026-04-24T13:18:40-07:002/20/20モデルがAQUILA基準を上回り、高リスクのスモールリング多発性骨髄腫を識別 https://news.medxy.ai/vi/model-aquila-smoldering-multiple-myeloma/Medxy AIvi2026-04-24T13:17:56-07:002/20/20 Model Hiệu Quả Hơn AQUILA Trong Việc Xác Định Smoldering Multiple Myeloma Có Nguy Cơ Cao https://news.medxy.ai/model-outperforms-aquila-2/Medxy AIen2026-04-24T13:15:45-07:002/20/20 Model Outperforms AQUILA Criteria in Identifying High-Risk Smoldering Multiple Myeloma https://news.medxy.ai/zh/icu-cultural-diversity/Medxy AIzh2026-04-24T12:59:08-07:00ICU中的文化多样性：对抗败血症死亡率的意外保护因素 https://news.medxy.ai/ja/icu-cultural-diversity-2/Medxy AIja2026-04-24T12:58:29-07:00ICUにおける文化的多様性：敗血症死亡率に対する驚くべき保護因子 https://news.medxy.ai/vi/cultural-diversity-emergency-medicine/Medxy AIvi2026-04-24T12:57:01-07:00Đa dạng văn hóa trong Khoa Hồi sức cấp cứu: Yếu tố bảo vệ bất ngờ chống lại tỷ lệ tử vong do nhiễm trùng https://news.medxy.ai/cultural-diversity-icu-sepsis/Medxy AIen2026-04-24T12:54:39-07:00Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality https://news.medxy.ai/zh/legend-trial-innovation/Medxy AIzh2026-04-24T12:24:02-07:00LEGEND试验：急诊科急性心肌梗死快速排除策略的革新者 https://news.medxy.ai/ja/legend-trial-acute-mi-exclusion/Medxy AIja2026-04-24T12:23:13-07:00LEGEND試験：急性心筋梗塞の迅速除外におけるゲームチェンジャー https://news.medxy.ai/vi/legend-trial-acute-heart-attack/Medxy AIvi2026-04-24T12:21:44-07:00Thử nghiệm LEGEND: Một cuộc cách mạng trong việc loại trừ nhanh chóng nhồi máu cơ tim cấp tính tại khoa cấp cứu https://news.medxy.ai/legend-trial-acute-mi/Medxy AIen2026-04-24T12:18:44-07:00LEGEND Trial: A Game-Changer in Rapid Rule-Out of Acute Myocardial Infarction in the ED https://news.medxy.ai/zh/video-statement-cancer-care-2/Medxy AIzh2026-04-24T12:06:52-07:00视频声明：弥合晚期癌症护理对话中的差距 https://news.medxy.ai/ja/video-declaration-filling-gaps/Medxy AIja2026-04-24T12:06:14-07:00ビデオ宣言：進行がんケア会話のギャップを埋める https://news.medxy.ai/vi/video-statements-cancer-care/Medxy AIvi2026-04-24T12:05:45-07:00Các Tuyên bố qua Video: Cầu nối trong Cuộc trò chuyện Chăm sóc Ung thư Giai đoạn Cuối https://news.medxy.ai/video-declarations-cancer-care/Medxy AIen2026-04-24T12:03:43-07:00Video Declarations: Bridging the Gap in Advanced Cancer Care Conversations https://news.medxy.ai/zh/family-dementia-screening/Medxy AIzh2026-04-24T11:58:19-07:00家族成员痴呆筛查：里程碑试验未发现明显益处或危害 https://news.medxy.ai/vi/dementia-screening-trial-results/Medxy AIvi2026-04-24T11:56:17-07:00Sàng lọc chứng mất trí cho thành viên gia đình: Thử nghiệm mang tính đột phá không tìm thấy lợi ích hoặc tác hại rõ ràng https://news.medxy.ai/dementia-screening-trial/Medxy AIen2026-04-24T11:53:45-07:00Dementia Screening for Family Members: No Clear Benefit or Harm Found in Landmark Trial https://news.medxy.ai/zh/osprey-trial-submandibular-stimulation/Medxy AIzh2026-04-24T11:35:37-07:00OSPREY试验：近端舌下神经刺激对中重度阻塞性睡眠呼吸暂停显示出希望 https://news.medxy.ai/ja/ospree-trial-sleep-apnea/Medxy AIja2026-04-24T11:34:22-07:00OSPREE試験：近位舌下神経刺激が中等度から重度の睡眠時無呼吸症候群に有望な結果を示す https://news.medxy.ai/vi/submandibular-nerve-stimulation-osa/Medxy AIvi2026-04-24T11:31:26-07:00Kích thích thần kinh dưới lưỡi gần hứa hẹn cho OSA trung bình đến nặng trong thử nghiệm OSPREY mang tính đột phá https://news.medxy.ai/hypoglossal-nerve-stimulation-osa/Medxy AIen2026-04-24T11:28:26-07:00Proximal Hypoglossal Nerve Stimulation Shows Promise for Moderate-to-Severe OSA in Landmark OSPREY Trial https://news.medxy.ai/zh/joint-antiviral-therapy-hhv-6b-survival/Medxy AIzh2026-04-24T10:46:48-07:00联合抗病毒治疗改善脐血移植后HHV-6B脑炎患者的生存率 https://news.medxy.ai/ja/fcn-gcv-antiviral-therapy/Medxy AIja2026-04-24T10:45:55-07:00FCN/GCV併用抗ウイルス療法が、無菌性骨髄移植後のHHV-6B脳炎の生存率を改善 https://news.medxy.ai/vi/hhv-6b-virus-therapy/Medxy AIvi2026-04-24T10:44:48-07:00Liệu pháp kháng virus kết hợp cải thiện tỷ lệ sống sót trong viêm não HHV-6B sau cấy ghép máu cuống rốn https://news.medxy.ai/antiviral-therapy-hhv6b-encephalitis/Medxy AIen2026-04-24T10:41:27-07:00Combination Antiviral Therapy Improves Survival in HHV-6B Encephalitis Post-Cord Blood Transplant https://news.medxy.ai/zh/innovative-ittp-therapy/Medxy AIzh2026-04-24T10:24:37-07:00革新iTTP治疗：反向CAR T细胞精准靶向自身反应性B细胞 https://news.medxy.ai/ja/ittp-therapy-revolution/Medxy AIja2026-04-24T10:23:59-07:00iTTP治療の革命: 逆CAR T細胞が自反応性B細胞を精密に標的化 https://news.medxy.ai/vi/revolutionizing-ttp-treatment/Medxy AIvi2026-04-24T10:23:00-07:00Cách mạng hóa điều trị iTTP: Tế bào CAR T ngược nhắm mục tiêu vào tế bào B tự miễn với độ chính xác cao https://news.medxy.ai/revolutionizing-ittp-treatment/Medxy AIen2026-04-24T10:20:36-07:00Revolutionizing iTTP Treatment: Reverse CAR T Cells Target Autoreactive B Cells with Precision https://news.medxy.ai/zh/genomic-fusion-breakpoints-2/Medxy AIzh2026-04-24T09:26:30-07:00基因组融合断点：儿童急性淋巴细胞白血病微小残留病监测的突破 https://news.medxy.ai/ja/genomic-fusion-breakpoints/Medxy AIja2026-04-24T09:25:04-07:00ゲノミックフュージョンブレークポイント：小児ALLのMRDモニタリングにおける画期的な進展 https://news.medxy.ai/vi/genetic-breakpoint-mrd-monitoring/Medxy AIvi2026-04-24T09:23:37-07:00Điểm đứt gãy hợp gen: Một bước đột phá trong giám sát MRD ở ALL nhi khoa https://news.medxy.ai/genomic-fusion-breakthrough/Medxy AIen2026-04-24T09:20:59-07:00Genomic Fusion Breakpoints: A Breakthrough in Pediatric ALL MRD Monitoring https://news.medxy.ai/zh/slow-but-stable-results/Medxy AIzh2026-04-24T09:17:49-07:00缓慢但稳定：t(11;14)骨髓瘤在四联疗法下尽管MRD阴性延迟仍表现出更优结果 https://news.medxy.ai/ja/steady-progress-multiple-myeloma/Medxy AIja2026-04-24T09:16:59-07:00ゆっくりと着実に：t(11;14)多発性骨髄腫は4剤併用療法によるMRD陰性化の遅れにもかかわらず優れた結果を示す https://news.medxy.ai/vi/stable-t1114-myeloma-results/Medxy AIvi2026-04-24T09:16:00-07:00Chậm nhưng ổn định: t(11;14) Myeloma cho thấy kết quả tốt hơn mặc dù có sự âm tính MRD bị chậm trễ với liệu pháp bốn thuốc https://news.medxy.ai/slow-steady-myeloma-outcomes/Medxy AIen2026-04-24T09:12:42-07:00Slow but Steady: t(11;14) Myeloma Shows Superior Outcomes Despite Delayed MRD Negativity with Quadruplet Therapy https://news.medxy.ai/zh/antifungal-treatment-covid-mortality/Medxy AIzh2026-04-24T00:02:35-07:00抗真菌治疗显著降低 COVID-19 相关肺曲霉病死亡率：欧洲数据证实 https://news.medxy.ai/ja/antifungal-therapy-covid-death-rate/Medxy AIja2026-04-24T00:01:23-07:00抗真菌療法がCOVID-19関連肺アスペルギローシスの死亡率を大幅に低下させる：ヨーロッパのデータが確認 https://news.medxy.ai/vi/fungal-treatment-covid19/Medxy AIvi2026-04-24T00:00:20-07:00Điều trị kháng nấm giảm tỷ lệ tử vong trong viêm phổi do nấm Aspergillus liên quan đến COVID-19: Dữ liệu châu Âu xác nhận https://news.medxy.ai/antifungal-therapy-covid-aspergillosis/Medxy AIen2026-04-23T23:56:55-07:00Antifungal Therapy Slashes Mortality in COVID-19-Associated Pulmonary Aspergillosis: European Data Confirms https://news.medxy.ai/zh/whole-genome-sequencing-vs-gene-panel/Medxy AIzh2026-04-23T23:24:03-07:00全基因组测序在先天性白内障诊断中的表现优于基因panel https://news.medxy.ai/ja/whole-genome-analysis-genetic-panel/Medxy AIja2026-04-23T23:23:02-07:00全ゲノム配列解析が先天性白内障の診断で遺伝子パネルを上回る https://news.medxy.ai/vi/genetic-analysis-cataracts/Medxy AIvi2026-04-23T23:21:37-07:00Phân tích toàn bộ bộ gen hiệu quả hơn bảng gen trong việc chẩn đoán đục thủy tinh thể bẩm sinh https://news.medxy.ai/whole-genome-sequencing-cataracts/Medxy AIen2026-04-23T23:17:38-07:00Whole Genome Sequencing Outperforms Gene Panels in Diagnosing Congenital Cataracts https://news.medxy.ai/zh/personalized-glaucoma-coaching-2/Medxy AIzh2026-04-23T22:07:35-07:00个性化青光眼辅导计划提高药物依从性20%：SEE项目试验结果 https://news.medxy.ai/ja/glaucoma-coaching-results/Medxy AIja2026-04-23T22:05:53-07:00個別化の緑内障コーチングが服薬順守率を20％向上：SEEプログラム試験結果 https://news.medxy.ai/vi/personalized-glaucoma-training/Medxy AIvi2026-04-23T22:04:27-07:00Huấn luyện cá nhân hóa Glaucoma tăng cường tuân thủ thuốc 20%: Kết quả thử nghiệm chương trình SEE https://news.medxy.ai/personalized-glaucoma-coaching/Medxy AIen2026-04-23T22:01:19-07:00Personalized Glaucoma Coaching Boosts Medication Adherence by 20%: SEE Program Trial Results https://news.medxy.ai/zh/pseudosyndrome-glaucoma-risk/Medxy AIzh2026-04-23T19:58:25-07:00假性剥脱综合征中的高青光眼风险：年龄和眼内压升高驱动发病率 https://news.medxy.ai/ja/pseudodrusen-glaucoma-risk/Medxy AIja2026-04-23T19:57:40-07:00偽剥離症候群における高緑内障リスク：年齢と眼圧亢進が発症を促進 https://news.medxy.ai/vi/glaucoma-risk-age-io-pressure/Medxy AIvi2026-04-23T19:56:34-07:00Nguy cơ glaucoma cao trong hội chứng bong tróc giả: Tuổi tác và tăng nhãn áp thúc đẩy tần suất https://news.medxy.ai/high-glaucoma-risk-pseudoexfoliation/Medxy AIen2026-04-23T19:53:22-07:00High Glaucoma Risk in Pseudoexfoliation Syndrome: Age and Ocular Hypertension Drive Incidence https://news.medxy.ai/zh/thyroidectomy-calcium-supplementation/Medxy AIzh2026-04-23T18:27:09-07:00甲状腺切除术后钙补充策略：常规与PTH指导补充效果相当 https://news.medxy.ai/vi/calcium-strategy-thyroid-surgery/Medxy AIvi2026-04-23T18:25:19-07:00Chiến lược canxi sau cắt tuyến giáp: Bổ sung thường quy so với bổ sung hướng dẫn bởi PTH có hiệu quả tương tự https://news.medxy.ai/post-thyroidectomy-calcium-strategies/Medxy AIen2026-04-23T18:21:31-07:00Post-Thyroidectomy Calcium Strategies: Routine vs. PTH-Guided Supplementation Show Similar Efficacy https://news.medxy.ai/zh/rai-outperforms-mfi-5-2/Medxy AIzh2026-04-23T18:20:36-07:00RAI 在预测 UPPP 术后并发症方面优于 mFI-5：体弱分层突破 https://news.medxy.ai/ja/rai-outperforms-mfi-5-3/Medxy AIja2026-04-23T18:19:28-07:00RAIはmFI-5を上回り、UPPP後の合併症予測に成功：虚弱度層別化のブレイクスルー https://news.medxy.ai/vi/rai-vuot-troi-hon-mf5/Medxy AIvi2026-04-23T18:17:59-07:00RAI vượt trội hơn mFI-5 trong dự đoán biến chứng sau UPPP: Một bước đột phá trong phân loại suy yếu https://news.medxy.ai/rai-outperforms-mfi-5/Medxy AIen2026-04-23T18:14:35-07:00RAI Outperforms mFI-5 in Predicting Post-UPPP Complications: A Frailty Stratification Breakthrough https://news.medxy.ai/zh/robotic-gastrectomy-superior/Medxy AIzh2026-04-23T17:47:14-07:00机器人胃切除术在胃癌治疗效果上优于开放手术和腹腔镜手术 https://news.medxy.ai/ja/robot-surgery-gastric-cancer/Medxy AIja2026-04-23T17:46:31-07:00ロボット手術が胃がんの治療成績で開腹手術と内視鏡手術を上回る https://news.medxy.ai/vi/robot-gastric-surgery-advantage/Medxy AIvi2026-04-23T17:44:45-07:00Phẫu thuật robot dạ dày vượt trội hơn phẫu thuật mở và nội soi trong kết quả ung thư dạ dày https://news.medxy.ai/robotic-gastrectomy-outcomes/Medxy AIen2026-04-23T17:42:23-07:00Robotic Gastrectomy Outperforms Open and Laparoscopic Surgery in Gastric Cancer Outcomes https://news.medxy.ai/zh/higher-pre-hospital-trauma-patient-volume/Medxy AIzh2026-04-23T16:37:46-07:00较高的院前急救人员创伤患者接诊量与较低的早期死亡率相关 https://news.medxy.ai/ja/emergency-care-trauma-relations/Medxy AIja2026-04-23T16:36:56-07:00救急医療従事者の外傷患者数の増加と早期死亡率低下の関連 https://news.medxy.ai/vi/injured-patient-ratio/Medxy AIvi2026-04-23T16:36:16-07:00Số lượng bệnh nhân chấn thương cao hơn của nhân viên y tế cấp cứu liên kết với tỷ lệ tử vong sớm thấp hơn ở bệnh nhân chấn thương https://news.medxy.ai/higher-ems-trauma-volume/Medxy AIen2026-04-23T16:33:59-07:00Higher EMS Clinician Trauma Volume Linked to Lower Early Mortality in Trauma Patients https://news.medxy.ai/zh/aortic-repair-window-branch/Medxy AIzh2026-04-23T16:20:46-07:00带窗和分支腔内主动脉修复术在复杂主动脉瘤中的应用：5年生存率达80% https://news.medxy.ai/ja/promising-evar-results/Medxy AIja2026-04-23T16:19:45-07:00分枝型および窓開設型EVAR、5年生存率80％で複雑な大動脈瘤に有望 https://news.medxy.ai/vi/endovascular-surgery-80-percent-survival/Medxy AIvi2026-04-23T16:18:16-07:00Phẫu thuật nội mạch có cửa sổ và nhánh hứa hẹn trong điều trị phình động mạch chủ phức tạp với tỷ lệ sống sót 80% sau 5 năm https://news.medxy.ai/fenestrated-branched-evar-survival/Medxy AIen2026-04-23T16:15:13-07:00Fenestrated and Branched EVAR Shows Promise in Complex Aortic Aneurysms with 80% Survival at 5 Years https://news.medxy.ai/zh/selective-universal-ngs-emc-cost-benefit/Medxy AIzh2026-04-23T15:32:29-07:00选择性与普遍性NGS在子宫内膜癌中的应用：成本效益突破 https://news.medxy.ai/ja/endometrial-cancer-sequencing/Medxy AIja2026-04-23T15:31:51-07:00子宮内膜がんにおける選択的次世代シーケンスと包括的次世代シーケンス: コスト効率性の革新 https://news.medxy.ai/vi/selective-vs-universal-ngs/Medxy AIvi2026-04-23T15:30:41-07:00Đánh giá chọn lọc so với phổ quát NGS trong ung thư nội mạc tử cung: Một bước đột phá về hiệu quả kinh tế https://news.medxy.ai/selective-universal-ngs-endometrial-cancer/Medxy AIen2026-04-23T15:28:29-07:00Selective vs. Universal NGS in Endometrial Cancer: A Cost-Efficiency Breakthrough https://news.medxy.ai/zh/postpartum-hypertension-opportunities/Medxy AIzh2026-04-23T15:04:57-07:0044% 的妊娠高血压疾病女性在10年内发展为慢性高血压：产后护理中的错失机会 https://news.medxy.ai/ja/hdp-women-chronic-hypertension/Medxy AIja2026-04-23T15:04:10-07:00妊娠高血圧症候群（HDP）の女性の44％が10年以内に慢性高血圧を発症：産褥期ケアにおける見落とし https://news.medxy.ai/vi/missed-opportunity-postpartum-care/Medxy AIvi2026-04-23T15:03:11-07:0044% phụ nữ mắc HDP phát triển huyết áp cao mãn tính trong vòng 10 năm: Cơ hội bị bỏ lỡ trong chăm sóc sau sinh https://news.medxy.ai/women-hdp-chronic-hypertension/Medxy AIen2026-04-23T15:00:47-07:0044% of Women with HDP Develop Chronic Hypertension Within 10 Years: Missed Opportunities in Postpartum Care https://news.medxy.ai/zh/study-finds-third-pregnancy-reduces-neurodevelopment-risk/Medxy AIzh2026-04-23T14:00:45-07:00研究发现：三胎妊娠中胎儿减数显著降低神经发育风险 https://news.medxy.ai/vi/study-reduces-neurodevelopment-risk/Medxy AIvi2026-04-23T13:58:57-07:00Nghiên cứu cho thấy giảm thai từ ba phôi sang hai phôi trong thai kỳ ba phôi giảm đáng kể nguy cơ phát triển thần kinh https://news.medxy.ai/fetal-reduction-triplets/Medxy AIen2026-04-23T13:56:37-07:00Fetal Reduction in Triplet Pregnancies Significantly Reduces Neurodevelopmental Risks, Study Finds https://news.medxy.ai/zh/bleeding-hypertension-infections-2/Medxy AIzh2026-04-23T12:32:09-07:00研究发现出血、高血压疾病和感染是严重孕产妇发病率的主要潜在原因 https://news.medxy.ai/ja/bleeding-hypertension-infections/Medxy AIja2026-04-23T12:30:55-07:00出血、高血圧障害、感染が重症母体モルビディティの主要な原因であることが研究で判明 https://news.medxy.ai/vi/bleeding-bp-disorders-infections/Medxy AIvi2026-04-23T12:29:04-07:00Nghiên cứu tìm thấy xuất huyết, rối loạn huyết áp và nhiễm trùng là nguyên nhân cơ bản hàng đầu gây ra tình trạng bệnh nặng nghiêm trọng ở sản phụ https://news.medxy.ai/maternal-morbidity-causes/Medxy AIen2026-04-23T12:26:06-07:00Hemorrhage, Hypertensive Disorders, and Infection Are the Leading Underlying Causes of Severe Maternal Morbidity, Study Finds https://news.medxy.ai/zh/risk-stratification-framework/Medxy AIzh2026-04-23T11:41:10-07:00通过风险分层模型优化肝细胞癌监测的新框架 https://news.medxy.ai/ja/improving-liver-cancer-monitoring/Medxy AIja2026-04-23T11:40:08-07:00肝細胞がんの監視をリスク層別化モデルで改善する新しいフレームワーク https://news.medxy.ai/vi/new-framework-liver-cancer-monitoring/Medxy AIvi2026-04-23T11:38:28-07:00Một Khung Mới để Tinh chỉnh Giám sát Ung thư Tế bào Gan với Mô hình Phân loại Nguy cơ https://news.medxy.ai/new-framework-hepatocellular-cancer/Medxy AIen2026-04-23T11:35:36-07:00A New Framework to Refine Hepatocellular Cancer Surveillance with Risk Stratification Models https://news.medxy.ai/zh/misfolded-proteins-in-gut/Medxy AIzh2026-04-23T09:12:30-07:00肠道中的蛋白质错误折叠：未来神经退行性疾病的窗口 https://news.medxy.ai/ja/abnormal-protein-folding/Medxy AIja2026-04-23T09:11:37-07:00腸内のタンパク質の異常折りたたみ：将来の神経変性疾患への窓 https://news.medxy.ai/vi/sai-gap-protein-ruot/Medxy AIvi2026-04-23T09:10:24-07:00Sai gập protein trong ruột: Một cửa sổ vào sự thoái hóa thần kinh trong tương lai https://news.medxy.ai/protein-misfolding-gut/Medxy AIen2026-04-23T09:07:57-07:00Protein Misfolding in the Gut: A Window into Future Neurodegeneration